Agilent Technologies Inc has introduced an integrated solution that combines their xCELLigence RTCA HT platform with the BioTek BioSpa 8 Automated Incubator. Click to read more.
24.02.2023 - Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination .
Data Bridge Market Research analyses that the stem cell therapy market, which is USD 257 million in 2022, is expected to reach USD 921.12 million by 2030,.
BANGALORE, India, Feb. 9, 2023 /PRNewswire/ Single Cell Analysis Market is segmented By Product (Consumables, Instruments), By Technique(Flow Cytometry, Next Generation Sequencing (NGS),